General Guidance
Click here for Dudley Guidelines for Promotion of Urinary Continence in Females and of Lower Urinary Tract Symptoms (LUTS) in Males
Please note Versomni is no longer formulary, however whilst the guidance is being updated, the current guidance remains active except for the section on Versomni.
Recommended drugs
Oxybutynin tablets standard and modified release ££
Tolterodine standard and modified release £££
Fesoterodine modified-release £££ - To be used 2nd line if unsuccessful with tolterodine in line with local guidelines
Solifenacin £££
Solifenacin with tamsulosin hydrochloride (Vesomni) £££
Trospium £££
Duloxetine £££
Oxybutynin transdermal patch (for patients unable to tolerate oral agents £££
Meatal Dilators (Prescribed following the recommendation of Continence Team)
Drug Traffic Light Key:
Green – On Formulary
Amber – Restricted use, see local guidelines
Purple – Specialist use/initiation
Red – Non Formulary
Relative Costs Key (where indicated):
£££££ - high
£££ - moderate
£ - low